Insulin and glucagon action in the liver
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at how insulin and glucagon (hormones that control blood sugar) affect the liver. It may help us understand how the body regulates sugar and could lead to better treatments for diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 45 years old.
- You are generally healthy and do not have active medical conditions.
- Your body mass index (BMI) is less than 27.
- Your blood sugar levels are normal.
- You do not have diabetes or a family history of diabetes in your immediate family.
- You are not pregnant and do not take certain medications that affect blood sugar.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with fatty liver and type 2 diabetes respond to glucagon, a hormone that helps control blood sugar. It may help researchers understand a condition called 'glucagon resistance' and find better treatments.
This study looks at how glucagon affects insulin release and blood sugar in people who do not have type 2 diabetes. It may help us understand normal glucose control better.
This study tests whether very low-carbohydrate diets change glucagon response in adults with type 1 diabetes. It may help researchers understand how diet affects blood-sugar control in people using insulin pumps and continuous glucose monitors.
This Phase 2 study tests how glucagon affects sugar and fat handling in the liver after a short period of calorie restriction. It may help researchers understand metabolic changes in people with type 2 diabetes and guide future treatments.
This study will use MRI scans to see how a natural hormone called glucagon changes blood flow to the kidneys in healthy people. The results may help future research on kidney health.
This study looks at how the body makes glucagon (a hormone that raises blood sugar) in children and teens with new type 1 diabetes. It aims to understand why some people may have dangerous low blood sugars, so doctors can better prevent them in the future.
Hear when a new Diabetes (DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.